The Thalidomide tragedy will always be part of our company’s history. We are committed to keeping the memory alive by continuously making more information available.
On this page, you can find information about the history of the Thalidomide tragedy, as well as current news and developments related to Thalidomide, and insights into how Grünenthal supports Thalidomide-affected people around the globe today.
Gabriel Baertschi, CEO Grünenthal
The history of the Thalidomide tragedy
Thalidomide: The active substance and its consequences
12/20/2023
Grünenthal welcomes national apology for Thalidomide survivors by Australian Prime Minister
On November 29th, 2023, Australian Prime Minister Anthony Albanese issued an apology in the name of the Australian Parliament for the role of the Australian government in the thalidomide tragedy. The apology was addressed at Australian thalidomide survivors, who have been campaigning for recognition for years.
More11/27/2021
60 Years after the market withdrawal: Dr. Michael Wirtz apologises to those affected on behalf of his family
On the occasion of 60 years after the market withdrawal of Thalidomide, Dr. Michael Wirtz, shareholder of Grünenthal, apologised to those affected and their families on behalf of his family. As company, we welcome this step.
MoreContact
Contact information for journalists and Thalidomide-affected people
Fabia Kehren
Head of Corporate Citizenship - Contact for the public
The Grünenthal Foundation for the Support of Thalidomide-Affected People
Phone +49 (0) 241 569 3269
E-Mail Fabia.Kehren@grunenthal.com
Susanne Schmitt-Degenhardt
Contact for people affected by Thalidomide
The Grünenthal Foundation for the Support of Thalidomide-Affected People
Phone +49 241 569 3699
